SCHEMBL18303

SCHEMBL18303

CC1(C)C(=O)NCCN1C[C@H]1CN(S(=O)(=O)C2=CC=CCC2=S)CCN1c1ccc([C@](C)(O)C(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 12/20 0.47
GCKR Q14397 8/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12079457 1.00 GCK (0.47) GCKGCKR
SCHEMBL12078856 1.00 GCK (0.47) GCKGCKR
SCHEMBL12080125 0.88 GCK (0.48) GCKGCKR
SCHEMBL12078465 0.88 GCK (0.48) GCKGCKR
SCHEMBL12078257 0.88 GCK (0.48) GCKGCKR
SCHEMBL17899 0.85 GCK (0.49) GCKGCKR
SCHEMBL17474 0.85 GCK (0.49) GCKGCKR
SCHEMBL22841 0.85 GCK (0.49) GCKGCKR
SCHEMBL17435 0.85 GCK (0.48) GCKGCKR
SCHEMBL17010 0.85 GCK (0.48) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed